About Us
Team
Senior Team
Board of Directors
Industry Expert Advisors
Portfolio
Funds & Strategy
Asia Pacific Healthcare Fund II
BioScience Managers Translation Fund I
BioScience Managers Ventures Fund I
News & Media
Contact Us
Menu
Menu
LinkedIn
Portfolio
Current portfolio
All
13
/
Asia Pacific Healthcare Fund II
5
/
BioScience Managers Translation Fund I
7
/
BioScience Managers Ventures Fund I
8
/
Board of Directors
0
/
Downing FOUR Healthcare Share Class
0
/
Exited
0
/
Invested - Exited
0
/
Invested - Exited APHFII
0
/
Invested Exited - BTF
0
/
Management Team
0
/
Portfolio
0
/
Team
0
Acrux use in-house capabilities to develop and commercialise pharmaceutical products for global markets
Develops, manufactures and supplies digital health technologies
Focused on the development of bacteriophage for the treatment of bacterial infection
Developing novel drugs for inflamatory and immune diseases
Canary Medical Inc. develops medical implant and data management devices
Cynata Therapeutics Limited is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™
Consisting of an interactive watch that collects movement data, proprietary algorithms and a detailed report
Humanetix software automates administration through work-flow, giving users more time and energy for their most important tasks
Identifying disease through transcriptomics and mutation detection
Nutrition and Technology Intelligence
Pioneer of the REX Robot that enhances the mobility of wheelchair users
Closed loop neuromodulation technology to record and measure electrical nerve signals
Manufacturer of high quality fish oils (omega-3 and omega-2)
Exited portfolio
Developing and commercialising specialty and generic topical pharmaceuticals
Drug development with FDA approved drug (fondaparinux) and oncology pipeline
Protein engineering technology platform to transform proteins into potent drug candidates
Regenerative products for the treatment of a broad range of wounds, scars and skin defects.
Making better treatments for cancer and central nervous system disorders
Now known as Aviragen Therapeutics, Inc. Focused on the development of direct-acting antivirals.
Committed to bringing science to wellbeing
Less-invasive, miniaturized, mechanical circulatory support technologies for advanced heart failure
Developing therapies for neurological disorders
PETization™ technology to develop novel biologic therapies for companion animals
Advancing and commercialising innovative medical dermatology products
Portfolio of inflammation and fibrosis products at various stages of development and approval
Load more
Scroll to top